Mobile

Health Assessment, Patient treatment satisfaction and Quality-of-Life in insulin-naive type 2 diabetes Patients uncontrolled on OHA treatment initiating basal insulin therapy with either insulin glarg...

Update Il y a 4 ans
Reference: EUCTR2009-010913-59

Health Assessment, Patient treatment satisfaction and Quality-of-Life in insulin-naive type 2 diabetes Patients uncontrolled on OHA treatment initiating basal insulin therapy with either insulin glargine or NPH insulin added to therapies with oral hypoglycemic agents. A multicenter, prospective, crossover, open randomized clinical phase-IV trial

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Investigate the impact of insulin glargine vs. NPH basal insulin on a composite diabetes related quality of life score (DRQoL), consisting of a standardized and unweighted Insulin Treatment Experience Questionnaire Score (ITEQ), the Problem Areas in Diabetes Questionnaire score (PAID) and the mental health score of the SF 12® Health Survey (SF 12®). The treatments consist of a combination therapy of oral antidiabetic agents and either insulin glargine or NPH basal insulin

Inclusion criteria

  • Diabetes Mellitus, Type 2

Links